Xeris Pharmaceuticals, Inc.
The Director, CMC provides leadership for the Chemistry, Manufacturing and Controls (CMC) function for Xeris commercial and clinical/late-stage development products. This role provides subject matter expertise for all aspects of Drug Substance (API), Drug Product, and Combination/Device product development against the applicable regulations and standards in preparation for post-approval changes and submission of Regulatory Market Approvals by USFDA and other Health Authorities.